United States Callable Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-07-27
https://bondscovery.com/yield-curve/usd-corporate-healthcare-pharmaceuticals-united-states-callable
United States Callable Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-07-27: 10Y at 5.44%, fitted curve 1M–40Y (4.54%–6.05%), 634 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 1M | 4.54% | — |
| 3M | 4.55% | 4.56% |
| 6M | 4.58% | 4.61% |
| 9M | 4.61% | 4.66% |
| 12M | 4.63% | 4.71% |
| 18M | 4.69% | 4.79% |
| 2Y | 4.74% | 4.90% |
| 3Y | 4.85% | 5.07% |
| 4Y | 4.96% | 5.29% |
| 5Y | 5.07% | 5.50% |
| 6Y | 5.17% | 5.68% |
| 7Y | 5.26% | 5.80% |
| 8Y | 5.33% | 5.85% |
| 9Y | 5.39% | 5.87% |
| 10Y | 5.44% | 5.92% |
| 15Y | 5.80% | 6.51% |
| 20Y | 5.96% | 6.45% |
| 25Y | 6.02% | 6.25% |
| 30Y | 6.04% | 6.15% |
| 40Y | 6.05% | 6.09% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.74% and the 10-year 5.44%, a 10Y−2Y spread of +70 bp — positively sloped — as of 2026-07-27. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-07-27 | 1m ago2026-06-26 | 2m ago2026-05-28 | 3m ago2026-04-28 | 4m ago2026-03-30 | 5m ago2026-02-27 | 6m ago2026-01-28 |
|---|---|---|---|---|---|---|---|
| 2Y | 4.74% | 4.56% | 4.45% | 4.37% | 4.45% | 3.97% | 4.10% |
| 10Y | 5.44% | 5.14% | 5.28% | 5.12% | 5.25% | 4.84% | 4.89% |
| 10Y − 2Y | +70 bp | +58 bp | +83 bp | +76 bp | +80 bp | +87 bp | +79 bp |
Yields by rating group
The same curve split by credit quality: 699 rated bonds across 3 rating bands, all maturities pooled. Median yield by band: AAA to AA- 5.27%, A+ to BBB- 5.38%, Speculative 6.24%.
Bonds in this curve
A selection of 30 of the 701 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Illumina INC | 5.68% | 2026-09-09 | 4.65% | US452327AQ25 |
| Agilent Technologies INC | 5.24% | 2026-09-22 | 3.05% | US00846UAK79 |
| Cardinal Health INC | 5.45% | 2026-11-15 | 4.70% | US14149YBQ08 |
| Abbvie INC | 4.56% | 2026-11-21 | 2.95% | US00287YBV02 |
| ELI Lilly & CO | 4.50% | 2027-02-09 | 4.50% | US532457CJ56 |
| Stryker Corp | 4.71% | 2027-02-10 | 4.55% | US863667BJ94 |
| CVS Health Corp | 4.81% | 2027-04-01 | 3.62% | US126650DH04 |
| ELI Lilly & CO | 4.43% | 2027-05-15 | 3.10% | US532457BP26 |
| Cardinal Health INC | 4.53% | 2027-06-15 | 3.41% | US14149YBJ64 |
| ELI Lilly & CO | 4.34% | 2027-08-14 | 4.15% | US532457CP17 |
| Amgen INC | 4.54% | 2027-11-02 | 3.20% | US031162CQ15 |
| Bristol-Myers Squibb CO | 4.49% | 2027-11-13 | 1.12% | US110122DP08 |
| Organon & CO | 5.25% | 2028-04-30 | 4.12% | USU6835WAA28 |
| Merck & CO INC | 4.58% | 2028-05-17 | 4.05% | US58933YBH71 |
| CVS Health Corp | 4.88% | 2029-01-30 | 5.00% | US126650DW70 |
| HCA INC | 5.12% | 2029-02-01 | 5.88% | US404119BW86 |
| Stryker Corp | 4.87% | 2030-02-10 | 4.85% | US863667BL41 |
| ELI Lilly & CO | 4.68% | 2030-02-12 | 4.75% | US532457CV84 |
| Bristol-Myers Squibb CO | 4.91% | 2031-02-01 | 5.75% | US110122DY15 |
| CVS Health Corp | 5.06% | 2031-01-30 | 5.25% | US126650DX53 |
| ELI Lilly & CO | 4.85% | 2032-02-12 | 4.90% | US532457CW67 |
| Cencora INC | 5.20% | 2033-02-13 | 4.60% | US03073EBD67 |
| Thermo Fisher Scientific INC | 5.20% | 2034-01-31 | 5.20% | US883556DB50 |
| Stryker Corp | 5.27% | 2035-02-10 | 5.20% | US863667BM24 |
| Cencora INC | 5.48% | 2036-02-13 | 4.90% | US03073EBE41 |
| Amgen INC | 5.78% | 2039-02-01 | 6.40% | US031162BA71 |
| Thermo Fisher Scientific INC | 5.86% | 2044-02-01 | 5.30% | US883556BG65 |
| Boston Scientific Corp | 5.81% | 2049-03-01 | 4.70% | US101137AU14 |
| ELI Lilly & CO | 5.86% | 2054-02-09 | 5.00% | US532457CM85 |
| Merck & CO INC | 6.00% | 2061-12-10 | 2.90% | US58933YBG98 |